TISSUE SPECIFIC GENE THERAPY FOR HUMAN PROSTATE CANCER

Project: Research project

StatusFinished
Effective start/end date4/1/975/31/10

Funding

  • National Institutes of Health: $265,033.00
  • National Institutes of Health: $279,518.00
  • National Institutes of Health
  • National Institutes of Health: $109,429.00
  • National Institutes of Health: $102,328.00
  • National Institutes of Health: $272,949.00
  • National Institutes of Health: $279,518.00
  • National Institutes of Health: $88,366.00
  • National Institutes of Health: $105,249.00
  • National Institutes of Health: $18,057.00
  • National Institutes of Health: $265,033.00

Fingerprint

Prostate-Specific Antigen
Genetic Therapy
Androgens
Prostatic Neoplasms
Adenoviridae
Prostate
Neoplasms
human glutamate carboxypeptidase II
Organ Culture Techniques
Contracts
Luciferases
Therapeutics
Apoptosis
Mutation

ASJC

  • Medicine(all)